U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07655570) titled 'Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma' on June 15.
Brief Summary: This is a pilot study evaluating the efficacy and safety of ivonescimab in subjects with advanced or metastatic cutaneous angiosarcoma who have previously been treated with taxane-based chemotherapy.
Study Start Date: Nov. 30, 2026
Study Type: INTERVENTIONAL
Condition:
Cutaneous Angiosarcoma
Intervention:
DRUG: Ivonescimab
Given by IV
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Published by HT Digital Content Services with permission from Health Daily Digest....